BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 20486867)

  • 21. Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21.
    Addison CL; Ding K; Zhao H; Le Maître A; Goss GD; Seymour L; Tsao MS; Shepherd FA; Bradbury PA
    J Clin Oncol; 2010 Dec; 28(36):5247-56. PubMed ID: 21079146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
    Tran TA; Kallakury BV; Ambros RA; Ross JS
    Cancer; 1998 Jul; 83(2):276-82. PubMed ID: 9669810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells.
    Kane S; Prentice MA; Mariano JM; Cuttitta F; Jakowlew SB
    Anticancer Res; 2002; 22(3):1433-44. PubMed ID: 12168820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
    Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
    Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta1 and TNF-alpha after red blood cell transfusion in colorectal cancer patients.
    Milasiene V; Stratilatovas E; Characiejus D; Kazbariene B; Norkiene V
    Exp Oncol; 2007 Mar; 29(1):67-70. PubMed ID: 17431392
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
    Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
    Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of circulating plasma DNA as a diagnostic tool for advanced non-small cell lung cancer and its predictive utility for survival and response to chemotherapy.
    Kumar S; Guleria R; Singh V; Bharti AC; Mohan A; Das BC
    Lung Cancer; 2010 Nov; 70(2):211-7. PubMed ID: 20181407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
    Eliopoulos DG; Mavroudi I; Pontikoglou C; Ximeri M; Stavroulaki E; Pyrovolaki K; Velegraki M; Spanoudakis M; Goulielmos G; Papadaki HA
    Eur J Haematol; 2009 Dec; 83(6):535-40. PubMed ID: 19614955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
    Nakagawa T; Yamaguchi M
    J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significance of expression of TGF-beta in pulmonary metastasis in non-small cell lung cancer tissues.
    Saji H; Nakamura H; Awut I; Kawasaki N; Hagiwara M; Ogata A; Hosaka M; Saijo T; Kato Y; Kato H
    Ann Thorac Cardiovasc Surg; 2003 Oct; 9(5):295-300. PubMed ID: 14672525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
    Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
    Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-treatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer.
    Feltl D; Závadová E; Pála M; Hozák P
    Neoplasma; 2005; 52(5):393-7. PubMed ID: 16151583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.
    Vollmer RT; Govindan R; Graziano SL; Gamble G; Garst J; Kelley MJ; Christenson RH
    Clin Cancer Res; 2003 May; 9(5):1728-33. PubMed ID: 12738727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
    Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
    Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of curcumin on TNF-alpha and TGF-beta1 in serum and lung tissue of SiO2-induced fibrosis in mice].
    Jiang ZY; Zou L; Shi SS; Lu YR; Dong J; Yang CH; Lu YC; Dai GK
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):399-401. PubMed ID: 19426594
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dynamics of plasma transforming growth factor beta 1 (TGF-beta1) level during radiotherapy with or without simultaneous chemotherapy in advanced head and neck cancer.
    Feltl D; Zavadova E; Pala M; Hozak P
    Oral Oncol; 2005 Feb; 41(2):208-13. PubMed ID: 15695123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer.
    van der Drift MA; Hol BE; Klaassen CH; Prinsen CF; van Aarssen YA; Donders R; van der Stappen JW; Dekhuijzen PN; van der Heijden HF; Thunnissen FB
    Lung Cancer; 2010 May; 68(2):283-7. PubMed ID: 19632736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragile X-related protein FXR1 controls post-transcriptional suppression of lipopolysaccharide-induced tumour necrosis factor-alpha production by transforming growth factor-beta1.
    Khera TK; Dick AD; Nicholson LB
    FEBS J; 2010 Jul; 277(13):2754-65. PubMed ID: 20491901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.